ProStocks Logo
Unlimited Trades ₹899 Monthly
www.ProStocks.com
Contact us

Trident Texofab IPO vs Vanta Bioscience IPO

Comparison between Trident Texofab IPO and Vanta Bioscience IPO.

IPO Details

Trident Texofab IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vanta Bioscience IPO is a SME Fixed Price proposed to list at BSE SME.

 Trident Texofab IPOVanta Bioscience IPO
LogoTrident Texofab IPO LogoVanta Bioscience IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeFixed PriceFixed Price
Listing AtBSE SMEBSE SME
Lead ManagersOneview Corporate Advisors Pvt.Ltd.Inventure Merchant Banker Services Pvt.Ltd.
RegistrarKfin Technologies Ltd.Bigshare Services Pvt.Ltd.
Market MakerGuiness Securities Ltd.Inventure Growth & Securities Ltd.
DRHPDRHP DRHP
RHPRHP RHP
Final ProspectusFinal Prospectus Final Prospectus
IPO Allotment URLIPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Trident Texofab IPO is up to ₹3.34 Cr whereas the issue size of the Vanta Bioscience IPO is up to ₹7.17 Cr. The final issue price of Trident Texofab IPO is ₹30.00 per share and of Vanta Bioscience IPO is ₹50.00 per share.

 Trident Texofab IPOVanta Bioscience IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹30.00 per share₹50.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares3000 shares
Fresh Issue Size11,12,000 shares14,34,000 shares
Fresh Issue Size (Amount)up to ₹3.34 Crup to ₹7.17 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total11,12,000 shares14,34,000 shares
Issue Size Total (Amount)up to ₹3.34 Crup to ₹7.17 Cr

IPO Timetable

Trident Texofab IPO opens on Sep 21, 2017, while Vanta Bioscience IPO opens on Sep 25, 2017. The closing date of Trident Texofab IPO and Vanta Bioscience IPO is Sep 26, 2017, and Sep 27, 2017, respectively.

 Trident Texofab IPOVanta Bioscience IPO
Issue OpenSep 21, 2017Sep 25, 2017
Issue CloseSep 26, 2017Sep 27, 2017
Basis Of Allotment (Tentative)Sep 29, 2017
Listing date (Tentative)Oct 05, 2017Oct 06, 2017

Financials & KPIs

Trident Texofab IPO P/E ratio is , as compared to Vanta Bioscience IPO P/E ratio of .

 Trident Texofab IPOVanta Bioscience IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets24.5037.9928.42
Total Income76.1966.0362.65
Profit After Tax0.340.060.18
NET Worth3.803.463.43
Reserves and Surplus3.473.133.10
Total Borrowing5.182.983.56
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 2017
Assets13.75
NET Worth6.09
Reserves and Surplus6.15
Total Borrowing7.51
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100.00%98.43%
Promoter Shareholding (Post-Issue)70.57%72.45%
Market Cap₹11.99 Cr.₹28.64 Cr.

Shares Offered

In the Trident Texofab IPO Retail Individual Investors (RII) are offered 5,56,000 shares while in Vanta Bioscience IPO retail investors are offered 5,56,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Trident Texofab IPO and 0 shares in Vanta Bioscience IPO.

 Trident Texofab IPOVanta Bioscience IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation64,000 shares78,000 shares
QIB0 shares0 shares
NII5,56,000 shares7,17,000 shares
RII5,56,000 shares7,17,000 shares
Employee0 shares0 shares
Total11,12,000 shares14,34,000 shares

Bids Received (Subscription)

Trident Texofab IPO subscribed 8.09x in total, whereas Vanta Bioscience IPO subscribed 1.44x.

 Trident Texofab IPOVanta Bioscience IPO
NII (times)3.45x1.52x
RII (times)12.73x1.36x
Total (times)8.09x1.44x

Compare with others

Trident Texofab IPOVanta Bioscience IPO
Share India Securities IPOCadsys IPO
Mehai Technology IPOInnovative Tyres IPO
Airo Lam IPOTrident Texofab IPO
Cadsys IPOAKM Lace IPO
Innovative Tyres IPOMadhya Pradesh Today Media IPO
AKM Lace IPOD P Wires IPO
Madhya Pradesh Today Media IPOShree Tirupati Balajee FIBC IPO
Vanta Bioscience IPOR M Drip IPO
D P Wires IPOSri Krishna Metcom IPO
Shree Tirupati Balajee FIBC IPOWorth Peripherals IPO

Compare:

Trident Texofab IPO Vs Vanta Bioscience IPO